M.D.C. (MDC) Reaches New 12-Month High at $31.31
M.D.C. Holdings, Inc. (NYSE:MDC) hit a new 52-week high on Thursday . The stock traded as high as $31.31 and last traded at $31.21, with a volume of 65081 shares traded. The stock had previously closed at $30.88.
A number of research analysts have weighed in on MDC shares. Zacks Investment Research raised shares of M.D.C. from a “hold” rating to a “buy” rating and set a $35.00 target price on the stock in a research note on Wednesday. ValuEngine lowered shares of M.D.C. from a “hold” rating to a “sell” rating in a research note on Tuesday, January 22nd. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $34.00.
The stock has a market cap of $1.89 billion, a price-to-earnings ratio of 8.48, a price-to-earnings-growth ratio of 1.15 and a beta of 1.33. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.49 and a current ratio of 9.15.
In related news, SVP Michael Touff sold 36,741 shares of M.D.C. stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $28.84, for a total value of $1,059,610.44. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO David D. Mandarich sold 55,000 shares of M.D.C. stock in a transaction dated Monday, February 25th. The shares were sold at an average price of $29.65, for a total transaction of $1,630,750.00. The disclosure for this sale can be found here. Insiders have sold a total of 194,089 shares of company stock worth $5,611,678 over the last quarter. 26.30% of the stock is currently owned by insiders.
A number of large investors have recently modified their holdings of MDC. Comerica Bank raised its stake in M.D.C. by 0.7% in the fourth quarter. Comerica Bank now owns 49,645 shares of the construction company’s stock valued at $1,522,000 after purchasing an additional 338 shares in the last quarter. CIBC Private Wealth Group LLC boosted its stake in shares of M.D.C. by 1.0% in the fourth quarter. CIBC Private Wealth Group LLC now owns 36,901 shares of the construction company’s stock worth $1,037,000 after acquiring an additional 350 shares during the period. Piedmont Investment Advisors Inc. boosted its stake in shares of M.D.C. by 3.6% in the fourth quarter. Piedmont Investment Advisors Inc. now owns 10,780 shares of the construction company’s stock worth $303,000 after acquiring an additional 378 shares during the period. Legal & General Group Plc boosted its stake in shares of M.D.C. by 0.4% in the fourth quarter. Legal & General Group Plc now owns 108,282 shares of the construction company’s stock worth $3,047,000 after acquiring an additional 454 shares during the period. Finally, Bank of Montreal Can boosted its stake in shares of M.D.C. by 14.1% in the fourth quarter. Bank of Montreal Can now owns 4,908 shares of the construction company’s stock worth $138,000 after acquiring an additional 605 shares during the period. Hedge funds and other institutional investors own 84.59% of the company’s stock.
TRADEMARK VIOLATION WARNING: “M.D.C. (MDC) Reaches New 12-Month High at $31.31” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/m-d-c-mdc-reaches-new-12-month-high-at-31-31/2955639.html.
About M.D.C. (NYSE:MDC)
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
Featured Story: Why do earnings reports matter?
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.